Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
MEDICAL MARIJUANA STOCKS
(Total Views: 209)
Posted On: 02/02/2021 5:36:25 PM
Post# of 4861
Avatar
Posted By: toodles
Re: Kgem #2110
Johnson & Johnson one-dose COVID-19 shot offers strong protection, fuels concern about variants
A single-dose vaccine is a big advantage when most countries are struggling to get shots in arms more quickly.

The New York Times February 01, 2021 14:56:51 IST

Johnson & Johnson said that it planned to apply for emergency authorization of the vaccine from the Food and Drug Administration as soon as next week, putting it on track to receive clearance later in February.

“This is the pandemic vaccine that can make a difference with a single dose,” said Dr. Paul Stoffels, the chief scientific officer of Johnson & Johnson.

The company’s announcement comes as the Biden administration is pushing to immunize Americans faster even with a tight vaccine supply. White House officials have been counting on Johnson & Johnson’s vaccine to ease the shortfall. But the company may only have about 7 million doses ready when the FDA decides whether to authorize it, according to federal health officials familiar with its production, and about 30 million doses by early April.


https://www.firstpost.com/world/johnson-johns...9260271.ht


TOODLES

(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site